Literature DB >> 34519771

Humoral Immunity After mRNA SARS-CoV-2 Vaccination in Allogeneic HCT Recipients-Room for Improvement and Much to Learn.

Joshua A Hill1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34519771     DOI： 10.1001/jamanetworkopen.2021.27454

Source DB:  PubMed          Journal:  JAMA Netw Open        ISSN： 2574-3805


× No keyword cloud information.
  2 in total

1.  Prognostic Value of Immunotyping Combined with Targeted Therapy in Patients with Non-Small-Cell Lung Cancer and Establishment of Nomogram Model.

Authors:  Sha Tian; Yinmei Guo; Jiajun Fu; Zijing Li; Jing Li; Xuefei Tian
Journal:  Comput Math Methods Med       Date:  2022-05-14       Impact factor: 2.809

2.  The Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Japanese Patients after Allogeneic Stem Cell Transplantation.

Authors:  Marika Watanabe; Kimikazu Yakushijin; Yohei Funakoshi; Goh Ohji; Wataru Hojo; Hironori Sakai; Miki Saeki; Yuri Hirakawa; Sakuya Matsumoto; Rina Sakai; Shigeki Nagao; Akihito Kitao; Yoshiharu Miyata; Taiji Koyama; Yasuyuki Saito; Shinichiro Kawamoto; Mitsuhiro Ito; Tohru Murayama; Hiroshi Matsuoka; Hironobu Minami
Journal:  Vaccines (Basel)       Date:  2022-01-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.